Sonic Healthcare Acquires Germany's Diagnosticum for EUR190 Million
By Stuart Condie
SYDNEY--Australian pathology services provider Sonic Healthcare Ltd. agreed to pay 190 million euros (US$206.0 million) to acquire German laboratory chain Diagnosticum.
Sonic on Monday said that founder-led Diagnosticum, which operates 15 laboratories and employs 25 pathologists, is expected to generate 65 million euros of revenue in the 2024 fiscal year. Sonic reported 4.08 billion Australian dollars (US$2.73 billion) of revenue in 1H of fiscal 2023.
The all-cash acquisition is not material but will immediately be earnings-per-share accretive when it closes before the end of the 2023 calendar year, Sonic said. The majority of the purchase price is tax deductible in Germany over 15 years as goodwill amortization, it added.
Write to Stuart Condie at stuart.condie@wsj.com
(END) Dow Jones Newswires
April 02, 2023 19:34 ET (23:34 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom